Drug Profile
AZD 9272
Alternative Names: AZD 6538Latest Information Update: 23 Feb 2011
Price :
$50
*
At a glance
- Originator AstraZeneca; NPS Pharmaceuticals
- Class Analgesics; Small molecules
- Mechanism of Action Glutamate agonists; Glutamate receptor antagonists; Metabotropic glutamate receptor agonists; Metabotropic glutamate receptor antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Gastro-oesophageal reflux; Neurological disorders; Neuropathic pain
Most Recent Events
- 19 Feb 2007 Discontinued - Phase-I for Gastro-oesophageal reflux in USA (unspecified route)
- 02 Feb 2006 Phase-I clinical trials in Gastro-oesophageal reflux in USA (unspecified route)
- 02 Feb 2006 Phase-I clinical trials in Neuropathic pain in USA (unspecified route)